Published on
June 19, 2025
- 06:33 GMT
GENCURIX and QIAGEN Forge Strategic Global Partnership for Digital PCR-based Oncology Diagnostics
GENCURIX becomes inaugural partner in QIAGEN’s QIAcuityDx™ Partnering Program to drive global-standard precision diagnostics SEOUL, SOUTH KOREA, June 19, 2025 /EINPresswire.com/ -- GENCURIX, Inc., a leading molecular diagnostics company specializing in …
Distribution channels:
Business & Economy, Companies
...
